Synthesis and Antimycobacterial Evaluation of Novel Pyrazole‐Isoxazolines and Pyrazole‐Isoxazoles
ChemBioChem · 2024
DOI: 10.1002/cbic.202400414 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Paulo A Moraes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Química de Heterociclos (NUQUIMHE), Departamento de Química, Universidade Federal de Santa Maria, 97105-900, Santa Maria, RS, Brasil. Hauptthemen laut MEDLINE: Pyrazoles, Isoxazoles, Microbial Sensitivity Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
This study reports the synthesis of a new series of pyrazole‐isoxazolines, at very good yields, from the cyclocondensation reaction of pyrazole‐enaminones with hydroxylamine hydrochloride. Dehydration of the pyrazole‐isoxazolines furnished another new series of the respective pyrazole‐isoxazoles, at excellent yields. Both series of the obtained compounds were screened for antimycobacterial activity, and compounds 4 f and 5 c showed significant inhibition of bacterial growth with a time‐ and concentration‐dependent bactericidal effect. Cytotoxicity tests in VERO cell line did not indicate toxicity of compounds 4 f and 5 c regarding cellular prediction, NO production or dsDNA release. However, both compounds were associated with an increase in total ROS levels, providing induction of oxidative stress, but without compromising cellular targets. These results highlight compounds 4 f and 5 c as promising candidates for antimycobacterial treatment with a favorable safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Núcleo de Química de Heterociclos (NUQUIMHE), Departamento de Química, Universidade Federal de Santa Maria, 97105-900, Santa Maria, RS, Brasil.
- Laboratório de Micobacteriologia (LabMyco), Departamento de Análises Clínicas e Toxicológicas, Universidade Federal de Santa Maria, 97105-900, Santa Maria, RS, Brasil.
- Laboratório de Cultura Celular e Efeitos Bioativos (Labcultbio), Programa de Pós Graduação em Nanociências, Universidade Franciscana, 97010-493, Santa Maria, RS, Brasil.
ORCID-Profile: Nilo Zanatta
Förderung
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Moraes, P. A., Dill Fussinger, T., Fontana, T., Pereira, G. S., Marangoni, M. A., Camargo, A. F., Bonacorso, H. G., Martins, M. A. P., Machado, A. K., de Campos, M. M. A., & Zanatta, N. (2024). Synthesis and Antimycobacterial Evaluation of Novel Pyrazole‐Isoxazolines and Pyrazole‐Isoxazoles. ChemBioChem. https://doi.org/10.1002/cbic.202400414
Vancouver
Moraes PA, Dill Fussinger T, Fontana T, Pereira GS, Marangoni MA, Camargo AF, et al. Synthesis and Antimycobacterial Evaluation of Novel Pyrazole‐Isoxazolines and Pyrazole‐Isoxazoles. ChemBioChem. 2024. doi:10.1002/cbic.202400414
BibTeX
@article{Moraes2024,
author = {Moraes, Paulo A and Dill Fussinger, Thaise and Fontana, Tuyla and Pereira, Genilson S and Marangoni, Mário A and Camargo, Adriano F and Bonacorso, Helio G and Martins, Marcos A P and Machado, Alencar K and de Campos, Marli M A and Zanatta, Nilo},
title = {Synthesis and Antimycobacterial Evaluation of Novel Pyrazole‐Isoxazolines and Pyrazole‐Isoxazoles},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400414}
}
EUVIMED